Vladislav Sandler
Vladislav Sandler is the co-founder of HemoGenyx LLC, a US preclinical stage biotechnology company launching innovative new treatments for blood diseases using blood-forming (“hematopoietic”) stem cell transplantation (“HSCT”) techniques.
Latest posts by Vladislav Sandler (see all)
- Eliminating the need for bone marrow donors - 18th July 2017